Loading…

Metformin prevents airway hyperreactivity in rats with dietary obesity

Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and fem...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Lung cellular and molecular physiology 2021-12, Vol.321 (6), p.L1105-L1118
Main Authors: Calco, Gina N, Proskocil, Becky J, Jacoby, David B, Fryer, Allison D, Nie, Zhenying
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793
cites cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793
container_end_page L1118
container_issue 6
container_start_page L1105
container_title American journal of physiology. Lung cellular and molecular physiology
container_volume 321
creator Calco, Gina N
Proskocil, Becky J
Jacoby, David B
Fryer, Allison D
Nie, Zhenying
description Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.
doi_str_mv 10.1152/ajplung.00202.2021
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2605304426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</originalsourceid><addsrcrecordid>eNpVkF9LwzAUxYMobk6_gA9S8Lnz5n_6Iog4FSa-6HNIu3TL2Nqaphv99mZuDn0IN-Sce3L4IXSNYYwxJ3dm2ay6aj4GIEDG8eATNIwCSTEHdhrvwCAFAXyALtp2CQAcQJyjAWVCKIb5EE3ebChrv3ZV0ni7sVVoE-P81vTJom-s99YUwW1c6JNo8SbKWxcWyczZYHyf1Llto3iJzkqzau3VYY7Q5-Tp4_Elnb4_vz4-TNOCUQhpXhYzZaUwPE4sc0mLTCrBMkGwEsIKzJQpWHyTIEnOqYXMKsoxE9QomdERut_nNl2-trMi9vVmpRvv1rGNro3T_5XKLfS83mglIxMCMeD2EODrr862QS_rzlexsyYRFAXGiIgusncVvm5bb8vjDxj0jr0-sNc_7PWOfVy6-dvtuPILm34Dr_uCMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605304426</pqid></control><display><type>article</type><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><source>American Physiological Society Free</source><creator>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</creator><creatorcontrib>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</creatorcontrib><description>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</description><identifier>ISSN: 1040-0605</identifier><identifier>EISSN: 1522-1504</identifier><identifier>DOI: 10.1152/ajplung.00202.2021</identifier><identifier>PMID: 34668415</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antidiabetics ; Asthma ; Asthma - chemically induced ; Asthma - drug therapy ; Asthma - metabolism ; Asthma - pathology ; Body fat ; Body weight ; Body weight gain ; Bradycardia ; Bronchial Hyperreactivity - chemically induced ; Bronchial Hyperreactivity - drug therapy ; Bronchial Hyperreactivity - metabolism ; Bronchial Hyperreactivity - pathology ; Bronchoconstriction ; Bronchoconstrictor Agents - toxicity ; Diabetes mellitus ; Diet ; Diet, High-Fat - adverse effects ; Fasting ; Female ; Glucose ; Glucose - metabolism ; High fat diet ; Hyperinsulinism - etiology ; Hyperinsulinism - metabolism ; Hyperinsulinism - pathology ; Hyperinsulinism - prevention &amp; control ; Hypersensitivity ; Hypoglycemic Agents - pharmacology ; Insulin ; Insulin resistance ; Laboratory testing ; Low fat diet ; Male ; Males ; Metformin ; Metformin - pharmacology ; Methacholine ; Methacholine Chloride - toxicity ; Nutrient deficiency ; Obesity ; Obesity - complications ; Potentiation ; Rats ; Rats, Sprague-Dawley ; Respiratory tract ; Rodents ; Vagus nerve ; Vagus Nerve - drug effects ; Weight Gain ; Weight reduction</subject><ispartof>American journal of physiology. Lung cellular and molecular physiology, 2021-12, Vol.321 (6), p.L1105-L1118</ispartof><rights>Copyright American Physiological Society Dec 2021</rights><rights>Copyright © 2021 the American Physiological Society. 2021 American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</citedby><cites>FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</cites><orcidid>0000-0002-2521-5580 ; 0000-0003-1712-9831 ; 0000-0002-7803-6447 ; 0000-0001-6387-1813 ; 0000-0003-2195-9512</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Calco, Gina N</creatorcontrib><creatorcontrib>Proskocil, Becky J</creatorcontrib><creatorcontrib>Jacoby, David B</creatorcontrib><creatorcontrib>Fryer, Allison D</creatorcontrib><creatorcontrib>Nie, Zhenying</creatorcontrib><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><title>American journal of physiology. Lung cellular and molecular physiology</title><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><description>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</description><subject>Animals</subject><subject>Antidiabetics</subject><subject>Asthma</subject><subject>Asthma - chemically induced</subject><subject>Asthma - drug therapy</subject><subject>Asthma - metabolism</subject><subject>Asthma - pathology</subject><subject>Body fat</subject><subject>Body weight</subject><subject>Body weight gain</subject><subject>Bradycardia</subject><subject>Bronchial Hyperreactivity - chemically induced</subject><subject>Bronchial Hyperreactivity - drug therapy</subject><subject>Bronchial Hyperreactivity - metabolism</subject><subject>Bronchial Hyperreactivity - pathology</subject><subject>Bronchoconstriction</subject><subject>Bronchoconstrictor Agents - toxicity</subject><subject>Diabetes mellitus</subject><subject>Diet</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Fasting</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose - metabolism</subject><subject>High fat diet</subject><subject>Hyperinsulinism - etiology</subject><subject>Hyperinsulinism - metabolism</subject><subject>Hyperinsulinism - pathology</subject><subject>Hyperinsulinism - prevention &amp; control</subject><subject>Hypersensitivity</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Laboratory testing</subject><subject>Low fat diet</subject><subject>Male</subject><subject>Males</subject><subject>Metformin</subject><subject>Metformin - pharmacology</subject><subject>Methacholine</subject><subject>Methacholine Chloride - toxicity</subject><subject>Nutrient deficiency</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Potentiation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Respiratory tract</subject><subject>Rodents</subject><subject>Vagus nerve</subject><subject>Vagus Nerve - drug effects</subject><subject>Weight Gain</subject><subject>Weight reduction</subject><issn>1040-0605</issn><issn>1522-1504</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkF9LwzAUxYMobk6_gA9S8Lnz5n_6Iog4FSa-6HNIu3TL2Nqaphv99mZuDn0IN-Sce3L4IXSNYYwxJ3dm2ay6aj4GIEDG8eATNIwCSTEHdhrvwCAFAXyALtp2CQAcQJyjAWVCKIb5EE3ebChrv3ZV0ni7sVVoE-P81vTJom-s99YUwW1c6JNo8SbKWxcWyczZYHyf1Llto3iJzkqzau3VYY7Q5-Tp4_Elnb4_vz4-TNOCUQhpXhYzZaUwPE4sc0mLTCrBMkGwEsIKzJQpWHyTIEnOqYXMKsoxE9QomdERut_nNl2-trMi9vVmpRvv1rGNro3T_5XKLfS83mglIxMCMeD2EODrr862QS_rzlexsyYRFAXGiIgusncVvm5bb8vjDxj0jr0-sNc_7PWOfVy6-dvtuPILm34Dr_uCMg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Calco, Gina N</creator><creator>Proskocil, Becky J</creator><creator>Jacoby, David B</creator><creator>Fryer, Allison D</creator><creator>Nie, Zhenying</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2521-5580</orcidid><orcidid>https://orcid.org/0000-0003-1712-9831</orcidid><orcidid>https://orcid.org/0000-0002-7803-6447</orcidid><orcidid>https://orcid.org/0000-0001-6387-1813</orcidid><orcidid>https://orcid.org/0000-0003-2195-9512</orcidid></search><sort><creationdate>20211201</creationdate><title>Metformin prevents airway hyperreactivity in rats with dietary obesity</title><author>Calco, Gina N ; Proskocil, Becky J ; Jacoby, David B ; Fryer, Allison D ; Nie, Zhenying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antidiabetics</topic><topic>Asthma</topic><topic>Asthma - chemically induced</topic><topic>Asthma - drug therapy</topic><topic>Asthma - metabolism</topic><topic>Asthma - pathology</topic><topic>Body fat</topic><topic>Body weight</topic><topic>Body weight gain</topic><topic>Bradycardia</topic><topic>Bronchial Hyperreactivity - chemically induced</topic><topic>Bronchial Hyperreactivity - drug therapy</topic><topic>Bronchial Hyperreactivity - metabolism</topic><topic>Bronchial Hyperreactivity - pathology</topic><topic>Bronchoconstriction</topic><topic>Bronchoconstrictor Agents - toxicity</topic><topic>Diabetes mellitus</topic><topic>Diet</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Fasting</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose - metabolism</topic><topic>High fat diet</topic><topic>Hyperinsulinism - etiology</topic><topic>Hyperinsulinism - metabolism</topic><topic>Hyperinsulinism - pathology</topic><topic>Hyperinsulinism - prevention &amp; control</topic><topic>Hypersensitivity</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Laboratory testing</topic><topic>Low fat diet</topic><topic>Male</topic><topic>Males</topic><topic>Metformin</topic><topic>Metformin - pharmacology</topic><topic>Methacholine</topic><topic>Methacholine Chloride - toxicity</topic><topic>Nutrient deficiency</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Potentiation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Respiratory tract</topic><topic>Rodents</topic><topic>Vagus nerve</topic><topic>Vagus Nerve - drug effects</topic><topic>Weight Gain</topic><topic>Weight reduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Calco, Gina N</creatorcontrib><creatorcontrib>Proskocil, Becky J</creatorcontrib><creatorcontrib>Jacoby, David B</creatorcontrib><creatorcontrib>Fryer, Allison D</creatorcontrib><creatorcontrib>Nie, Zhenying</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calco, Gina N</au><au>Proskocil, Becky J</au><au>Jacoby, David B</au><au>Fryer, Allison D</au><au>Nie, Zhenying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin prevents airway hyperreactivity in rats with dietary obesity</atitle><jtitle>American journal of physiology. Lung cellular and molecular physiology</jtitle><addtitle>Am J Physiol Lung Cell Mol Physiol</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>321</volume><issue>6</issue><spage>L1105</spage><epage>L1118</epage><pages>L1105-L1118</pages><issn>1040-0605</issn><eissn>1522-1504</eissn><abstract>Increased insulin is associated with obesity-related airway hyperreactivity and asthma. We tested whether the use of metformin, an antidiabetic drug used to reduce insulin resistance, can reduce circulating insulin, thereby preventing airway hyperreactivity in rats with dietary obesity. Male and female rats were fed a high- or low-fat diet for 5 wk. Some male rats were simultaneously treated with metformin (100 mg/kg orally). In separate experiments, after 5 wk of a high-fat diet, some rats were switched to a low-fat diet, whereas others continued a high-fat diet for an additional 5 wk. Bronchoconstriction and bradycardia in response to bilateral electrical vagus nerve stimulation or to inhaled methacholine were measured in anesthetized and vagotomized rats. Body weight, body fat, caloric intake, fasting glucose, and insulin were measured. Vagally induced bronchoconstriction was potentiated only in male rats on a high-fat diet. Males gained more body weight, body fat, and had increased levels of fasting insulin compared with females. Metformin prevented development of vagally induced airway hyperreactivity in male rats on high-fat diet, in addition to inhibiting weight gain, fat gain, and increased insulin. In contrast, switching rats to a low-fat diet for 5 wk reduced body weight and body fat, but it did not reverse fasting glucose, fasting insulin, or potentiation of vagally induced airway hyperreactivity. These data suggest that medications that target insulin may be effective treatment for obesity-related asthma.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>34668415</pmid><doi>10.1152/ajplung.00202.2021</doi><orcidid>https://orcid.org/0000-0002-2521-5580</orcidid><orcidid>https://orcid.org/0000-0003-1712-9831</orcidid><orcidid>https://orcid.org/0000-0002-7803-6447</orcidid><orcidid>https://orcid.org/0000-0001-6387-1813</orcidid><orcidid>https://orcid.org/0000-0003-2195-9512</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1040-0605
ispartof American journal of physiology. Lung cellular and molecular physiology, 2021-12, Vol.321 (6), p.L1105-L1118
issn 1040-0605
1522-1504
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8715020
source American Physiological Society Free
subjects Animals
Antidiabetics
Asthma
Asthma - chemically induced
Asthma - drug therapy
Asthma - metabolism
Asthma - pathology
Body fat
Body weight
Body weight gain
Bradycardia
Bronchial Hyperreactivity - chemically induced
Bronchial Hyperreactivity - drug therapy
Bronchial Hyperreactivity - metabolism
Bronchial Hyperreactivity - pathology
Bronchoconstriction
Bronchoconstrictor Agents - toxicity
Diabetes mellitus
Diet
Diet, High-Fat - adverse effects
Fasting
Female
Glucose
Glucose - metabolism
High fat diet
Hyperinsulinism - etiology
Hyperinsulinism - metabolism
Hyperinsulinism - pathology
Hyperinsulinism - prevention & control
Hypersensitivity
Hypoglycemic Agents - pharmacology
Insulin
Insulin resistance
Laboratory testing
Low fat diet
Male
Males
Metformin
Metformin - pharmacology
Methacholine
Methacholine Chloride - toxicity
Nutrient deficiency
Obesity
Obesity - complications
Potentiation
Rats
Rats, Sprague-Dawley
Respiratory tract
Rodents
Vagus nerve
Vagus Nerve - drug effects
Weight Gain
Weight reduction
title Metformin prevents airway hyperreactivity in rats with dietary obesity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A00%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin%20prevents%20airway%20hyperreactivity%20in%20rats%20with%20dietary%20obesity&rft.jtitle=American%20journal%20of%20physiology.%20Lung%20cellular%20and%20molecular%20physiology&rft.au=Calco,%20Gina%20N&rft.date=2021-12-01&rft.volume=321&rft.issue=6&rft.spage=L1105&rft.epage=L1118&rft.pages=L1105-L1118&rft.issn=1040-0605&rft.eissn=1522-1504&rft_id=info:doi/10.1152/ajplung.00202.2021&rft_dat=%3Cproquest_pubme%3E2605304426%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-bfcd8e76a5cd817b73c978649621866e6148ac49787072b53e09e8351463a8793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2605304426&rft_id=info:pmid/34668415&rfr_iscdi=true